Ascent Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ascent Group, LLC

$1.29 Billion
Q3 2024

A detailed history of Ascent Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ascent Group, LLC holds 470 shares of REGN stock, worth $312,014. This represents 0.04% of its overall portfolio holdings.

Number of Shares

470

Previous 505 6.93%

Holding current value

$312,014

Previous $530,000 6.79%

% of portfolio

0.04%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $35,843 - $42,061	-35 Reduced 6.93%	470 $494,000
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $201,299 - $221,517	-223 Reduced 30.63%	505 $486,000
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $28,681 - $32,622	-37 Reduced 4.84%	728 $639,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $1.44 Million - $1.76 Million	-2,084 Reduced 73.15%	765 $629,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $723,831 - $858,581	1,034 Added 56.97%	2,849 $2.05 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $203,466 - $247,264	299 Added 19.72%	1,815 $1.49 Million
Q4 2022 Feb 16, 2023	BUY	$705.89 - $766.39 $82,589 - $89,667	117 Added 8.36%	1,516 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $263,452 - $332,462	459 Added 48.83%	1,399 $1.05 Million
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $183,148 - $246,772	334 Added 55.12%	940 $547,000
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $54,751 - $64,255	92 Added 17.9%	606 $423,000
Q4 2021 Mar 01, 2022	BUY	$543.48 - $670.97 $279,348 - $344,878	514 New	514 $319,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

84.6M

Call Options Held

1.29M

Put Options Held

1.47M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $71.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account